ramp down, page-34

Postmanpat,
Yes sirtex is on my radar - small number of shares on issue appears to be a good product and being well accepted, but big question mark over the ownership of the company and their IP. They are working through it but no-where near the stability of ownership at CST and its IP.
The other thing about cancer treatments is that practically every biotech is on the case to develop some treatment. Whilst I have no inkling of what is around the corner in such treatments one is bound to come along to displace SRX's treatment sooner than I expect will happen with a replacement LTBI test at CST.

Perhaps OOpeek has some other better value stock in mind.

redgum